| Detected | Trial | Change |
|---|---|---|
| 2026-06-12 | NCT07489495 A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell… |
Trial sites expanded: 25 -> 34 locations |
| 2026-06-11 | NCT07405177 A Study of MK-7240 in Healthy Participants (MK-7240-009) |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-10 | NCT07363590 A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004) |
Trial sites expanded: 12 -> 15 locations |
| 2026-06-10 | NCT07221474 A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in… |
Trial sites expanded: 47 -> 51 locations |
| 2026-06-09 | NCT07318558 A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer… |
Trial sites expanded: 77 -> 89 locations |
| 2026-06-09 | NCT06345729 A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS… |
Trial sites expanded: 222 -> 225 locations |
| 2026-06-09 | NCT07419295 A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer… |
Trial sites expanded: 42 -> 50 locations |
| 2026-06-09 | NCT06814145 Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023) |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-09 | NCT07489495 A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell… |
Trial sites expanded: 20 -> 25 locations |
| 2026-06-09 | NCT06997497 A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People… |
Trial sites expanded: 192 -> 196 locations |
| 2026-06-09 | NCT04924075 Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL)… |
Enrollment increased: 322 -> 355 participants |
| 2026-06-09 | NCT04924075 Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL)… |
date change Primary completion pushed: 2029-06-04 -> 2029-12-27 |
| 2026-06-09 | NCT04924075 Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL)… |
date change Completion pushed: 2029-06-04 -> 2029-12-27 |
| 2026-06-09 | NCT07405164 Extension Study for Participants in Studies That Include Belzutifan… |
Trial sites expanded: 15 -> 20 locations |
| 2026-06-09 | NCT07216703 A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab… |
Trial sites expanded: 115 -> 125 locations |
| 2026-06-09 | NCT07190248 A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With… |
Trial sites expanded: 170 -> 175 locations |
| 2026-06-09 | NCT07486960 Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015) |
Trial sites expanded: 38 -> 41 locations |
| 2026-06-09 | NCT04895722 Evaluation of Co-formulated Pembrolizumab/Quavonlimab (MK-1308A) Versus Other Treatments… |
Trial arms changed: 5 -> 7 |
| 2026-06-06 | NCT05017012 A Study to Evaluate the Bioavailability of Pembrolizumab (MK-3475) Via Subcutaneous (SC)… |
Trial completed |
| 2026-06-06 | NCT05017012 A Study to Evaluate the Bioavailability of Pembrolizumab (MK-3475) Via Subcutaneous (SC)… |
Enrollment increased: 72 -> 142 participants |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-08 | NCT07634471 A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007) | Phase 2/3 | Not Yet Recruiting |
| 2026-06-05 | NCT07630974 A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory… | Phase 1/2 | Not Yet Recruiting |
| 2026-06-02 | NCT07619443 A Clinical Study of MK-7262 and Enlicitide in Healthy Participants (MK-7262-003) | Phase 1 | Not Yet Recruiting |
| 2026-05-29 | NCT07614984 A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a)… | Phase 2 | Not Yet Recruiting |
| 2026-05-22 | NCT07600723 A Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) in… | Phase 4 | Not Yet Recruiting |
| 2026-05-22 | NCT07600749 Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors… | Phase 1 | Not Yet Recruiting |
| 2026-05-22 | NCT07600775 A Clinical Trial of MK-8527 and Rifampin in Adult Participants With Latent Tuberculosis… | Phase 1 | Not Yet Recruiting |
| 2026-05-19 | NCT07595263 A Study of Ulonivirine (MK-8507) and Methadone in Healthy Volunteers (MK-8507-019) | Phase 1 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07600723 | A Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) in… | Pulmonary Arterial Hypertension | Not Yet Recruiting |
| Phase 3 | |||
| NCT06351631 | A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017) | Thrombocythemia, Essential | Recruiting |
| NCT06136624 | Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003) | Prostate Cancer Metastatic | Recruiting |
| NCT07013487 | A Study to Evaluate V181 Dengue Vaccine in Healthy Participants 2 to 17 Years of Age… | Healthy | Recruiting |
| NCT06623422 | A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in… | Carcinoma, Non-Small-Cell Lung | Recruiting |
| NCT06655883 | A Study of Suvorexant (MK-4305) for the Treatment of Insomnia Disorder in Participants… | Insomnia | Recruiting |
| NCT05947851 | A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line… | Leukemia, Lymphocytic, Chronic, B-Cell | Recruiting |
| NCT06651281 | Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With… | Crohn Disease | Recruiting |
| NCT06312137 | A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab… | Non Small Cell Lung Cancer | Recruiting |
| NCT06077760 | A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus… | Non-small Cell Lung Cancer | Recruiting |
| NCT06136559 | A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib… | Chronic Lymphocytic Leukemia | Recruiting |
| NCT06841354 | A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination… | Triple Negative Breast Neoplasms | Recruiting |
| NCT06925737 | A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate… | Prostate Cancer | Recruiting |
| NCT06079879 | A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in… | Essential Thrombocythemia | Recruiting |
| NCT07071623 | A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010) | Human Immunodeficiency Virus (HIV) | Recruiting |
| NCT07159763 | A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza | Influenza | Recruiting |
| NCT06952504 | A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab… | Endometrial Cancer | Recruiting |
| NCT07431827 | MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC… | Non-small Cell Lung Cancer | Recruiting |
| NCT07554339 | A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell… | Non-small Cell Lung Cancer | Recruiting |
| NCT07227402 | A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer… | Renal Cell Carcinoma | Recruiting |
| NCT03486873 | Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who… | Solid Tumors | Recruiting |
| NCT06667700 | A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019… | Coronavirus Disease (COVID-19) | Recruiting |
| NCT06170788 | Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab… | Non-small Cell Lung Cancer (NSCLC) | Recruiting |
| NCT06312176 | A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With… | Breast Neoplasms | Recruiting |
| NCT06345729 | A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS… | Non-small Cell Lung Cancer | Recruiting |